Subscribe
Research
Innovative, independent, peer-reviewed. Explore the latest economic research and policy proposals from CGD’s global development experts.
TESTIMONY
Remarks to the European Parliament on EFSD/ EFSD+
September 24, 2025
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Research
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Research
WORKING PAPER
October 06, 2025
The paper reviews lessons from 17 global health panels to inform the design of the forthcoming Independent Panel for Evidence for Action against Antimicrobial Resistance (IPEA). It finds that IPEA’s effectiveness will depend less on structural design and more on strategic positioning—balancing indep...
WORKING PAPER
October 06, 2025
Antimicrobial resistance (AMR) represents one of the most pressing global health challenges, yet translating scientific evidence into effective policy has proven slow, uneven, and fragmented across contexts. To inform the design of a proposed Independent Panel for Evidence for Action (IPEA) against ...
WORKING PAPER
October 06, 2025
For the new Independent Panel on Evidence for Action against AMR to be effective, it will need to combine strong mandates, independence, transparent and inclusive membership, and robust evidence frameworks, while balancing agility, accountability, and inclusiveness. Lessons from international expert...
WORKING PAPER
October 01, 2025
The Intergovernmental Panel on Climate Change has become a reference point for the design of international scientific advisory bodies. This paper examines what lessons from its experience may inform the creation of a new global panel on antimicrobial resistance. Drawing on interviews, roundtable dis...
POLICY PAPER
September 30, 2025
Healthcare supply chain financing is critical to health system performance but remains neglected—often fragmented, donor-dependent, and inefficient—leading to stockouts and high out-of-pocket costs. With aid declining, the paper develops a new framework linking health financing and supply chains to ...
CGD NOTE
September 17, 2025
PEPFAR is still emerging from aid cuts, with major implications for lifesaving HIV services. About 65 percent of USAID’s PEPFAR awards have been reported terminated, accounting for 24 percent of planned funding. Terminated USAID awards were responsible for supporting an estimated 2.3 million people ...
WORKING PAPER
September 15, 2025
Noncommunicable diseases—driven by tobacco use, harmful alcohol consumption, and high-sugar diets—account for over 70 percent of global deaths and impose annual economic losses exceeding US $514 billion. Excise taxes on these health-harming products offer a dual benefit of reducing consumption and r...
